Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteriovenous Malformations | 4 | 2024 | 45 | 2.020 |
Why?
|
| Pulmonary Veins | 4 | 2024 | 93 | 1.950 |
Why?
|
| Embolization, Therapeutic | 9 | 2024 | 263 | 1.840 |
Why?
|
| Arteriovenous Fistula | 3 | 2023 | 53 | 1.780 |
Why?
|
| Device Removal | 7 | 2024 | 168 | 1.420 |
Why?
|
| Pulmonary Artery | 5 | 2024 | 319 | 1.410 |
Why?
|
| Radiography, Interventional | 8 | 2020 | 154 | 1.360 |
Why?
|
| Catheters, Indwelling | 5 | 2024 | 113 | 1.230 |
Why?
|
| Catheterization, Central Venous | 5 | 2014 | 114 | 1.050 |
Why?
|
| Stents | 3 | 2024 | 406 | 1.040 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2024 | 41 | 0.910 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2023 | 394 | 0.850 |
Why?
|
| Vena Cava Filters | 6 | 2014 | 97 | 0.780 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 277 | 0.780 |
Why?
|
| Liver Neoplasms | 5 | 2023 | 759 | 0.730 |
Why?
|
| Vena Cava, Inferior | 5 | 2014 | 143 | 0.680 |
Why?
|
| Pneumothorax | 2 | 2015 | 53 | 0.590 |
Why?
|
| Radiology, Interventional | 3 | 2021 | 69 | 0.580 |
Why?
|
| Catheter-Related Infections | 2 | 2014 | 23 | 0.580 |
Why?
|
| Treatment Outcome | 21 | 2024 | 8251 | 0.570 |
Why?
|
| Renal Dialysis | 3 | 2009 | 335 | 0.530 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 5 | 0.480 |
Why?
|
| Thorax | 1 | 2014 | 77 | 0.460 |
Why?
|
| Sutures | 1 | 2014 | 53 | 0.460 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2021 | 2664 | 0.460 |
Why?
|
| Central Venous Catheters | 1 | 2014 | 21 | 0.460 |
Why?
|
| Pulmonary Embolism | 4 | 2024 | 228 | 0.450 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2021 | 237 | 0.450 |
Why?
|
| Catheterization | 2 | 2014 | 237 | 0.440 |
Why?
|
| Suture Techniques | 1 | 2014 | 140 | 0.440 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2024 | 227 | 0.430 |
Why?
|
| Bacterial Infections | 1 | 2014 | 184 | 0.420 |
Why?
|
| Computed Tomography Angiography | 3 | 2024 | 146 | 0.420 |
Why?
|
| Venous Thrombosis | 2 | 2013 | 252 | 0.370 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2011 | 35 | 0.370 |
Why?
|
| Activated Protein C Resistance | 1 | 2010 | 1 | 0.360 |
Why?
|
| Protein C Deficiency | 1 | 2010 | 4 | 0.360 |
Why?
|
| Laminectomy | 1 | 2010 | 27 | 0.350 |
Why?
|
| Humans | 37 | 2024 | 89447 | 0.350 |
Why?
|
| Middle Aged | 20 | 2024 | 26010 | 0.350 |
Why?
|
| Prosthesis Failure | 2 | 2024 | 116 | 0.330 |
Why?
|
| Yttrium Radioisotopes | 4 | 2023 | 58 | 0.330 |
Why?
|
| Retrospective Studies | 14 | 2024 | 9068 | 0.290 |
Why?
|
| Anticoagulants | 2 | 2010 | 427 | 0.290 |
Why?
|
| Arm | 1 | 2007 | 98 | 0.290 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 96 | 0.280 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 1063 | 0.280 |
Why?
|
| Pipecolic Acids | 1 | 2006 | 14 | 0.280 |
Why?
|
| Aged | 14 | 2024 | 19186 | 0.280 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2007 | 71 | 0.270 |
Why?
|
| Male | 20 | 2024 | 42461 | 0.260 |
Why?
|
| Angiography | 3 | 2021 | 208 | 0.260 |
Why?
|
| Ischemia | 1 | 2007 | 251 | 0.260 |
Why?
|
| Risk Factors | 6 | 2015 | 5500 | 0.250 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 6817 | 0.240 |
Why?
|
| Ileal Diseases | 1 | 2004 | 26 | 0.230 |
Why?
|
| Fibrin | 1 | 2024 | 86 | 0.230 |
Why?
|
| Foreign-Body Migration | 1 | 2024 | 39 | 0.230 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2023 | 15 | 0.230 |
Why?
|
| Thrombosis | 1 | 2006 | 302 | 0.220 |
Why?
|
| Vascular Calcification | 1 | 2024 | 51 | 0.220 |
Why?
|
| Intestinal Obstruction | 1 | 2004 | 89 | 0.220 |
Why?
|
| Hematoma | 1 | 2004 | 108 | 0.220 |
Why?
|
| Diagnosis, Differential | 2 | 2024 | 1598 | 0.210 |
Why?
|
| Female | 21 | 2024 | 46267 | 0.210 |
Why?
|
| Cholangiocarcinoma | 1 | 2023 | 76 | 0.210 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 1725 | 0.210 |
Why?
|
| Bile Duct Neoplasms | 1 | 2023 | 90 | 0.210 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 861 | 0.200 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2024 | 244 | 0.200 |
Why?
|
| Hepatic Artery | 2 | 2021 | 84 | 0.200 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 2364 | 0.200 |
Why?
|
| Adult | 14 | 2024 | 26648 | 0.190 |
Why?
|
| Fistula | 1 | 2021 | 42 | 0.190 |
Why?
|
| Phlebography | 5 | 2014 | 68 | 0.190 |
Why?
|
| Vascularized Composite Allotransplantation | 1 | 2021 | 14 | 0.180 |
Why?
|
| Hospital Units | 1 | 2020 | 30 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 60 | 0.180 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.180 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 54 | 0.180 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 79 | 0.170 |
Why?
|
| Brachytherapy | 1 | 2021 | 121 | 0.170 |
Why?
|
| Young Adult | 6 | 2024 | 6323 | 0.170 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2021 | 242 | 0.160 |
Why?
|
| Social Media | 1 | 2020 | 95 | 0.150 |
Why?
|
| Medicare | 1 | 2021 | 425 | 0.150 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 233 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2020 | 579 | 0.130 |
Why?
|
| Time Factors | 5 | 2024 | 5341 | 0.130 |
Why?
|
| Incidence | 3 | 2015 | 1597 | 0.130 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.130 |
Why?
|
| Chest Tubes | 1 | 2015 | 24 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 975 | 0.130 |
Why?
|
| Adolescent | 4 | 2021 | 9272 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2015 | 2284 | 0.120 |
Why?
|
| Hemostatics | 2 | 2012 | 57 | 0.120 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 37 | 0.120 |
Why?
|
| Femoral Vein | 1 | 2014 | 39 | 0.120 |
Why?
|
| Brachiocephalic Veins | 1 | 2014 | 34 | 0.120 |
Why?
|
| Vena Cava, Superior | 1 | 2014 | 60 | 0.120 |
Why?
|
| Jugular Veins | 1 | 2014 | 74 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 2 | 2009 | 414 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2014 | 171 | 0.110 |
Why?
|
| Age Distribution | 1 | 2014 | 200 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 360 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2014 | 118 | 0.110 |
Why?
|
| Equipment Design | 1 | 2014 | 415 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 126 | 0.110 |
Why?
|
| Illinois | 1 | 2014 | 483 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 3667 | 0.100 |
Why?
|
| Endoleak | 1 | 2012 | 41 | 0.100 |
Why?
|
| Prosthesis Design | 4 | 2014 | 298 | 0.100 |
Why?
|
| Biopsy | 1 | 2015 | 1185 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 988 | 0.100 |
Why?
|
| Embolic Protection Devices | 1 | 2011 | 9 | 0.090 |
Why?
|
| Iliac Vein | 1 | 2011 | 30 | 0.090 |
Why?
|
| Sex Factors | 1 | 2014 | 1069 | 0.090 |
Why?
|
| Hernia, Hiatal | 1 | 2011 | 38 | 0.090 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2011 | 44 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 120 | 0.090 |
Why?
|
| Comorbidity | 1 | 2014 | 951 | 0.090 |
Why?
|
| Factor V | 1 | 2010 | 9 | 0.090 |
Why?
|
| Acrylic Resins | 1 | 2009 | 22 | 0.090 |
Why?
|
| Gelatin | 1 | 2009 | 26 | 0.090 |
Why?
|
| Hemoptysis | 1 | 2009 | 24 | 0.080 |
Why?
|
| Age Factors | 1 | 2014 | 1872 | 0.080 |
Why?
|
| Castleman Disease | 1 | 2009 | 14 | 0.080 |
Why?
|
| Hepatic Duct, Common | 1 | 2009 | 10 | 0.080 |
Why?
|
| Biliary Fistula | 1 | 2009 | 11 | 0.080 |
Why?
|
| Warfarin | 1 | 2010 | 104 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 70 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 168 | 0.080 |
Why?
|
| Biomarkers | 1 | 2015 | 1769 | 0.080 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2011 | 196 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 159 | 0.080 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 196 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 233 | 0.080 |
Why?
|
| Lung | 1 | 2014 | 1264 | 0.080 |
Why?
|
| Axillary Vein | 1 | 2007 | 5 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 758 | 0.080 |
Why?
|
| Brachial Artery | 1 | 2007 | 36 | 0.070 |
Why?
|
| Chicago | 3 | 2021 | 1428 | 0.070 |
Why?
|
| Hemofiltration | 1 | 2006 | 10 | 0.070 |
Why?
|
| Arginine | 1 | 2006 | 138 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 435 | 0.060 |
Why?
|
| Radiography | 1 | 2007 | 809 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 48 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2006 | 318 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 90 | 0.060 |
Why?
|
| Thrombolytic Therapy | 1 | 2006 | 232 | 0.060 |
Why?
|
| Enema | 1 | 2004 | 39 | 0.060 |
Why?
|
| Barium Sulfate | 1 | 2004 | 43 | 0.060 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2024 | 99 | 0.060 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2023 | 72 | 0.050 |
Why?
|
| Microspheres | 1 | 2023 | 108 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 209 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1170 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2004 | 712 | 0.050 |
Why?
|
| Retreatment | 1 | 2021 | 108 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 59 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2020 | 123 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 79 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 114 | 0.040 |
Why?
|
| Workload | 1 | 2020 | 129 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2015 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 817 | 0.040 |
Why?
|
| Contrast Media | 1 | 2004 | 1092 | 0.040 |
Why?
|
| United States | 2 | 2021 | 7005 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2760 | 0.040 |
Why?
|
| Infant | 1 | 2004 | 3164 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1720 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 157 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2013 | 2306 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 217 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 72 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 4297 | 0.030 |
Why?
|
| Manometry | 1 | 2011 | 44 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1903 | 0.020 |
Why?
|
| Contraindications | 1 | 2011 | 70 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 502 | 0.020 |
Why?
|
| Portal System | 1 | 2009 | 13 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 611 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2011 | 123 | 0.020 |
Why?
|
| Balloon Occlusion | 1 | 2009 | 29 | 0.020 |
Why?
|
| Liver Failure | 1 | 2009 | 67 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 123 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 110 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 782 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2009 | 274 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 261 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2011 | 260 | 0.020 |
Why?
|
| Thrombectomy | 1 | 2009 | 181 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 255 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 774 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2009 | 242 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1243 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 11772 | 0.020 |
Why?
|
| Graft Survival | 1 | 2009 | 901 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1844 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 2875 | 0.010 |
Why?
|
| Asthma | 1 | 2011 | 977 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 27396 | 0.010 |
Why?
|